News Articles on 'Hematology'

Back to All Specialties


Oncology and Hematology Specialists to use Deep Lens’ VIPER

Cancer care network Oncology and Hematology Specialists has collaborated with Deep Lens to integrate the latter’s artificial-intelligence (AI)-based clinical trial matching platform, VIPER. VIPER is designed using Deep Lens’ Cloud-based technology.

Source: Clinical Trials Arena
Published: 17 May 2021

Brooklyn Cancer Center names new chief of hematology and medical oncology

The Brooklyn Cancer Center has named board-certified hematologist-oncologist and experienced medical leader Maxim Shulimovich, D.O., as its new chief of hematology and medical oncology. His recruitment is a step in establishing the cancer center as a unified division to provide expert care and culturally sensitive services for patients with all types of cancer and blood

Source: Brooklyn Daily Eagle
Published: 14 May 2021

Curis Reports Updated Data in Two Abstracts for CA-4948 Accepted for Presentation at the European Hematology Association 2021 Virtual Congress

"The clinical data published in the abstract this morning are consistent with our preliminary findings reported late last year showing that CA-4948 has, in addition to encouraging safety characteristics,

Source: Business Insider
Published: 12 May 2021

BeiGene Highlights Progress in Hematology at EHA2021 Virtual Congress

(NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that clinical results from its broad hematology program will be presented at the 26 th European Hematology Association 2021 (EHA2021) Virtual Congress being held June 9 – 17,

Source: Associated Press
Published: 12 May 2021

Oncology and Hematology Specialists, P.A. and Deep Lens Partner to Integrate Clinical Trial Matching Solution VIPER™ Into Network, Expanding Offering to Patients

Deep Lens and Oncology and Hematology Specialists, P.A. today announced that they will partner to deploy artificial-intelligence (AI)-based trial matc

Source: Business Wire
Published: 14 May 2021

Global Hematology Market share 2021 market size, growth drivers, holistic analysis, latest trends forecast 2024

Global "Global HematologyMarket" (2021-2024) report identifies Sales of Market by regional analysis by product type

Source: MarketWatch
Published: 10 May 2021

Hematology Diagnostics Market- Prevalence of Blood-Related Disorders to Propel Demand

The hematology diagnostics market has witnessed the advent of a wide range of hematology testing solutions that combine the attributes of strainer, slider maker, and cell counter. Integrated solutions have been gaining ground in the hematology diagnostics ...

Source: PharmiWeb
Published: 06 May 2021

Semiautomatic Hematology Analyzers Market Share 2021: Global Trends, Key Players, Industry Analysis Report to 2027

Automation is one of the key technological advances in the hematology analyzer market. Hematology analyzer consists of several analysis modules with unique sample preparation procedures.

Source: openpr.com
Published: 13 May 2021

Omeros’ Narsoplimab Pivotal Trial Data to Be Shared as an Oral Presentation at the European Hematology Association Congress

Omeros Corporation today announced that data on organ function improvement from Omeros’ pivotal trial of narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy will be shared as an oral presentation at the 2021 European Hematology Association Virtual Congress.

Source: Nasdaq
Published: 13 May 2021

Global Hematology Analyzers (In Vitro Diagnostics) Market Analysis and Forecast Report 2020-2030 - ResearchAndMarkets.com

The "Hematology Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com's offering. Hematology ...

Source: thedailytimes.com
Published: 05 May 2021

Global Veterinary Hematology Analyzers Market 2021 Future Prospects, Industry-specific Challenges, Industry Projections, Sizes and Shares by 2026

MarketsandResearch.biz has added a new key research report titled Global Veterinary Hematology Analyzers Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 that offers insightful information like market share,

Source: MarketWatch
Published: 10 May 2021

Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that two poster presentations of new clinical data and analyses related to imetelstat, the Company’s first-in-class telomerase inhibitor,

Source: Financial Buzz
Published: 12 May 2021

Keros Therapeutics to Present at the Virtual 26th Annual Congress of the European Hematology Association

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need,

Source: Nasdaq
Published: 12 May 2021

GBT Announces Upcoming Data Presentations at European Hematology Association (EHA) 2021 Virtual Congress

(GBT) (NASDAQ: GBT) today announced that six abstracts related to its sickle cell disease (SCD) programs will be presented at the European Hematology Association (EHA) 2021 Virtual Congress, taking place online June 9-17,

Source: Morningstar, Inc.
Published: 12 May 2021

Oncopeptides presents new clinical and preclinical melflufen data at the upcoming European Hematology Association meeting

Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that new

Source: WFMZ-TV
Published: 12 May 2021

Apellis to Present Long-Term Pegcetacoplan Data in PNH at the European Hematology Association ...

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in targeted C3 therapies, today announced that seven abstracts were accepted for presentation and publication at the European Hematology Association (EHA) Virtual Congress to be held June 9-17,

Source: Associated Press
Published: 12 May 2021

Acceleron Announces Presentations on REBLOZYL (luspatercept-aamt) at the 2021 European Hematology Association Virtual Congress

Acceleron Pharma Inc. (Nasdaq: XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases,

Source: Financial Buzz
Published: 12 May 2021

The Brooklyn Cancer Center Announces New Chief of Hematology-Oncology

Brooklyn, NY, May 10, 2021 --(PR.com)-- The Brooklyn Cancer Center has named noted leader and board-certified hematologist-oncologist Maxim Shulimovich, DO, as its new Chief of Hematology and ...

Source: PR
Published: 10 May 2021

BeiGene Highlights Progress in Hematology at EHA2021 Virtual Congress

BeiGene’s Growing Hematology Clinical Portfolio Now Includes Potent and Highly Selective BCL-2 Candidate BGB-11417 In addition to the established BRUKINSA and tislelizumab programs, BeiGene ...

Source: Business Wire
Published: 12 May 2021

Global Hematology Analyzers (In Vitro Diagnostics) Market Analysis and Forecast Report 2020-2030 - ResearchAndMarkets.com

The "Hematology Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact)" report has been added to ResearchAndMarkets.com's offering. Hematology Analyzers (In Vitro Diagnostics) - Global Market Analysis and ...

Source: Yahoo Finance
Published: 05 May 2021